详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Zhu, Ji[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] * ; Sun, Xinchen[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Liu, Anwen[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Zhu, Yaqun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Zhang, Tao[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19]

; Liu, Luying[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Jia, Jianhui[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Tan, Shisheng[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Wu, Junxin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Wang, Xin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19]

; Zhou, Juying[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Yang, Jialin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19]

; Zhang, Chen[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Zhang, Hongyan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; He, Xinjia[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Cai, Gang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Zhang, Wei[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19]

; Cai, Sanjun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ; Zhang, Zhen[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19] ;

机构： [1]Fudan Univ, Canc Ctr, Shanghai, Peoples R China [2]Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Peoples Hosp, Nanjing, Peoples R China [3]Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China [4]Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China [5]Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China [6]Zhejiang Canc Hosp, Hangzhou, Peoples R China [7]Liaoning Canc Hosp & Inst, Shenyang, Peoples R China [8]Guizhou Prov Peoples Hosp, Guiyang, Peoples R China [9]Fujian Canc Hosp, Fuzhou, Peoples R China [10]Sichuan Univ, West China Hosp, Dept Radiat Oncol, Chengdu, Peoples R China [11]Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China [12]Sichuan Prov Canc Hosp, Dept Radiat Oncol, Chengdu, Peoples R China [13]Ningbo 2 Hosp, Ningbo, Peoples R China [14]Univ Sci & Technol China, Affiliated Hosp 1, Dept Radiat Oncol, Anhui Prov Hosp, Hefei, Peoples R China [15]Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China [16]Ruijin Hosp, Shanghai, Peoples R China [17]Fudan Univ, Shanghai, Peoples R China [18]Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China [19]Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China

出处：

DOI：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Fudan Univ, Canc Ctr, Shanghai, Peoples R China [2]Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Peoples Hosp, Nanjing, Peoples R China [3]Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China [4]Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China [5]Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China [6]Zhejiang Canc Hosp, Hangzhou, Peoples R China [7]Liaoning Canc Hosp & Inst, Shenyang, Peoples R China [8]Guizhou Prov Peoples Hosp, Guiyang, Peoples R China [9]Fujian Canc Hosp, Fuzhou, Peoples R China [10]Sichuan Univ, West China Hosp, Dept Radiat Oncol, Chengdu, Peoples R China [11]Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China [12]Sichuan Prov Canc Hosp, Dept Radiat Oncol, Chengdu, Peoples R China [13]Ningbo 2 Hosp, Ningbo, Peoples R China [14]Univ Sci & Technol China, Affiliated Hosp 1, Dept Radiat Oncol, Anhui Prov Hosp, Hefei, Peoples R China [15]Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China [16]Ruijin Hosp, Shanghai, Peoples R China [17]Fudan Univ, Shanghai, Peoples R China [18]Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China [19]Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.

文献详情